医渡科技中标重组人神经生长因子（SMR001）滴眼液Ⅲ期临床研究项目

Group 1 - The core point of the article is that Medu Technology announced that its affiliate, Tianjin Happy Life Technology Co., Ltd., has won a bid for a Phase III clinical research project for the recombinant human nerve growth factor (SMR001) eye drops from Shandong Yandu Biotechnology Co., Ltd. [1] - The total amount of the project is approximately 55.82 million RMB [1]